An interventional study of active transcranial direct current stimulation and bimanual training in Cerebral Palsy, Hemiplegic Cerebral Palsy and Spastic Hemiplegic Cerebral Palsy, sponsored by Burke Medical Research Institute. Status unknown at 1 site in United States. Open to participants aged 6 Years to 18 Years. Per ClinicalTrials.gov, last updated 2024-07-16.
Sponsored by Burke Medical Research Institute · Not applicable, Interventional, and Treatment
The goal of this study is to test the efficacy of transcranial direct current stimulation combined with bimanual training on hand function in children with unilateral spastic cerebral palsy (USCP). Children who enroll in the protocol will be randomized to receive either sham (not stimulating) tDCS plus bimanual training, or active (stimulating) tDCS plus bimanual training.
1,891 studies on the registry are indexed under Cerebral Palsy; 439 are open to participants now.
This study's planned enrollment of 80 is above the median of 34 across 1,396 interventional studies indexed under Cerebral Palsy.
Browse Cerebral Palsy studies →Burke Medical Research Institute is the lead sponsor of 15 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
In this arm, participants will engage in 120 min of bimanual training. Bimanual training involves using both hands to play with toys and games during the study. During the first 20 min of bimanual training, participants will receive active tDCS via sponges over the scalp.
Device: active transcranial direct current stimulation · Behavioral: bimanual training
In this arm, participants will engage in 120 min of bimanual training. Bimanual training involves using both hands to play with toys and games during the study. During the first 20 min of bimanual training, participants will wear the tDCS device that is worn by the active tDCS group, but in the sham group, participants will not receive stimulation during this 20 min period.
Behavioral: bimanual training
Participants will receive 20 min of tDCS over the scalp during the first 20 min of bimanual training.
Participants will engage in movements that use both hands, by playing with toys and games.
Change in Assisting Hand Assessment
Measure of how well the child uses both hands cooperatively for bimanual activities
Time frame: Day before intervention begins, compared to day after intervention ends (six days after intervention begins)
Jebsen-Taylor Test of Hand Function
Measure of movement speed of affected hand
Time frame: Day before intervention begins, compared to day after intervention ends (six days after intervention begins)
Box and Blocks test
Measure of movement speed of affected hand
Time frame: Day before intervention begins, compared to day after intervention ends (six days after intervention begins)
Plan to share: Yes — The investigators will share IPD via the NIH Data Hub (DASH), which is sponsored by NICHD.
Time frame: Data will be available when study is complete, and remain in DASH indefinitely.
Started Dec 2019 (actual). Primary completion is estimated for Jun 2025, 66 months after the start.
Of 882 non-industry interventional studies with no phase under Cerebral Palsy, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 31. This study's planned 66 months is above that.
Counting every sponsor, half of 900 studies reached it within 12 months; a quarter within 5 and three quarters within 31.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Burke Medical Research Institute